Hangzhou Tigermed Consulting Co Ltd - ESG Rating & Company Profile powered by AI
If you work at Hangzhou Tigermed Consulting Co Ltd and you would like to licence your Sustainability rating, please contact us. This ESG rating includes 17 UN SDGs including: 'Gender Equality', 'Reduced Inequalities' and 'Partnerships for the Goals'. The webpage is a zero-cost Sustainability assessment for Hangzhou Tigermed Consulting Co Ltd.
Hangzhou Tigermed Consulting Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.7; made up of an environmental score of 0.0, social score of 1.0 and governance score of 1.1.
0.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1894 | Chongqing Zhifei Biological Products Co Ltd | 0.8 | Low |
1894 | Valens Company Inc | 0.8 | Low |
1898 | Hangzhou Tigermed Consulting Co Ltd | 0.7 | Low |
1898 | CKD Bio Corp | 0.7 | Low |
1898 | Australis Capital Inc | 0.7 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Hangzhou Tigermed Consulting Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Hangzhou Tigermed Consulting Co Ltd disclose current and historical energy intensity?
Does Hangzhou Tigermed Consulting Co Ltd report the average age of the workforce?
Does Hangzhou Tigermed Consulting Co Ltd reference operational or capital allocation in relation to climate change?
Does Hangzhou Tigermed Consulting Co Ltd disclose its ethnicity pay gap?
Does Hangzhou Tigermed Consulting Co Ltd disclose cybersecurity risks?
Does Hangzhou Tigermed Consulting Co Ltd offer flexible work?
Does Hangzhou Tigermed Consulting Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Hangzhou Tigermed Consulting Co Ltd disclose the number of employees in R&D functions?
Does Hangzhou Tigermed Consulting Co Ltd conduct supply chain audits?
Does Hangzhou Tigermed Consulting Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Hangzhou Tigermed Consulting Co Ltd conduct 360 degree staff reviews?
Does Hangzhou Tigermed Consulting Co Ltd disclose the individual responsible for D&I?
Does Hangzhou Tigermed Consulting Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Hangzhou Tigermed Consulting Co Ltd disclose current and / or historical scope 2 emissions?
Does Hangzhou Tigermed Consulting Co Ltd disclose water use targets?
Does Hangzhou Tigermed Consulting Co Ltd have careers partnerships with academic institutions?
Did Hangzhou Tigermed Consulting Co Ltd have a product recall in the last two years?
Does Hangzhou Tigermed Consulting Co Ltd disclose incidents of discrimination?
Does Hangzhou Tigermed Consulting Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Hangzhou Tigermed Consulting Co Ltd issued a profit warning in the past 24 months?
Does Hangzhou Tigermed Consulting Co Ltd disclose parental leave metrics?
Does Hangzhou Tigermed Consulting Co Ltd disclose climate scenario or pathway analysis?
Does Hangzhou Tigermed Consulting Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Hangzhou Tigermed Consulting Co Ltd disclose the pay ratio of women to men?
Does Hangzhou Tigermed Consulting Co Ltd support suppliers with sustainability related research and development?
Does Hangzhou Tigermed Consulting Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Hangzhou Tigermed Consulting Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Hangzhou Tigermed Consulting Co Ltd involved in embryonic stem cell research?
Does Hangzhou Tigermed Consulting Co Ltd disclose GHG and Air Emissions intensity?
Does Hangzhou Tigermed Consulting Co Ltd disclose its waste policy?
Does Hangzhou Tigermed Consulting Co Ltd report according to TCFD requirements?
Does Hangzhou Tigermed Consulting Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Hangzhou Tigermed Consulting Co Ltd disclose energy use targets?
Does Hangzhou Tigermed Consulting Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Hangzhou Tigermed Consulting Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Hangzhou Tigermed Consulting Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in China and internationally. It operates through Clinical Trial Solutions; and Clinical-Related and Laboratory Services. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. It also provides integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital; medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value added services; and post-marketing study, real world evidence, and vaccine clinical trial services. The company was incorporated in 2004 and is headquartered in Hangzhou, China.